IMPROVE-AD

Trial ID or NCT#

NCT06087029

Status

not recruiting iconNOT RECRUITING

Purpose

The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for deterioration in patients with uncomplicated type B aortic dissection.

Official Title

IMPRoving Outcomes in Vascular DisEase- Aortic Dissection

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Dominik Fleischmann
Dominik Fleischmann
Radiologist, Cardiologist
Professor of Radiology (Cardiovascular Imaging)
John MacArthur
John MacArthur
Lung transplant surgeon, Cardiothoracic surgeon, Cardiac surgeon, Cardiovascular surgeon
Assistant Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)

View on ClinicalTrials.gov